1. Bosch G, Lin L, van Schie HTM, et al. Effect of extracorporeal shock wave therapy on the biochemical composition and metabolic activity of tenocytes in normal tendinous structures in ponies. Equine Vet J 2007; 39: 226–231.
2. Chen YJ, Wang CJ, Yang KD, et al. Extracorporeal shock waves promote healing of collagenase-induced Achilles tendinitis and increase TGF-β1 and IGF-I expression. J Orthop Res 2004; 22: 854–861.
3. Chao YH, Tsuang YH, Sun JS, et al. Effects of shock waves on tenocyte proliferation and extracellular matrix metabolism. Ultrasound Med Biol 2008; 34: 841–852.
4. Theoret CL. The pathophysiology of wound repair. Vet Clin North Am Equine Pract 2005; 21: 1–13.
5. Knottenbelt DC. Equine wound management: are there significant differences in healing at different sites on the body? Vet Dermatol 1997; 8: 273–290.
6. Lepault E, Céleste C, Doré M, et al. Comparative study on microvascular occlusion and apoptosis in body and limb wounds in the horse. Wound Repair Regen 2005; 13: 520–529.
7. Wilmink JM, Nederbragt H, van Weeren PR, et al. Differences in wound contraction between horses and ponies: the in vitro contraction capacity of fibroblasts. Equine Vet J 2001; 33: 499–505.
8. Haupt G, Chvapil M. Effect of shock waves on the healing of partial-thickness wounds in piglets. J Surg Res 1990; 49: 45–48.
9. Arnó A, García O, Hernán I, et al. Extracorporeal shock waves, a new non-surgical method to treat severe burns. Burns 2010; 36: 844–849.
10. Saggini R, Figus A, Troccola A, et al. Extracorporeal shock wave therapy for management of chronic ulcers in the lower extremities. Ultrasound Med Biol 2008; 34: 1261–1271.
11. Caminoto EH, Alves AL, Amorim RL, et al. Ultrastructural and immunocytochemical evaluation of the effects of extracorporeal shock wave treatment in the hind limbs of horses with experimentally induced suspensory ligament desmitis. Am J Vet Res 2005; 66: 892–896.
12. McClure SR, VanSickle D, Evans R, et al. The effects of extracorporeal shock-wave therapy on the ultrasonographic and histologic appearance of collagenase-induced equine forelimb suspensory ligament desmitis. Ultrasound Med Biol 2004; 30: 461–467.
13. Berta L, Fazzari A, Ficco AM, et al. Extracorporeal shock waves enhance normal fibroblast proliferation in vitro and activate mRNA expression for TGF-β1 and for collagen types I and III. Acta Orthop 2009; 80: 612–617.
14. Kersh KD, McClure SR, Van Sickle D, et al. The evaluation of extracorporeal shock wave therapy on collagenase induced superficial digital flexor tendonitis. Vet Comp Orthop Traumatol 2006; 19: 99–105.
15. Wang CJ. An overview of shock wave therapy in musculoskeletal disorders. Chang Gung Med J 2003; 26: 220–232.
16. Yan X, Zeng B, Chai Y, et al. Improvement of blood flow, expression of nitric oxide, and vascular endothelial growth factor by low-energy shockwave therapy in random-pattern skin flap model. Ann Plast Surg 2008; 61: 646–653.
17. Mittermayr R, Hartinger J, Antonic V, et al. Extracorporeal shock wave therapy (ESWT) minimizes ischemic tissue necrosis irrespective of application time and promotes tissue revascularization by stimulating angiogenesis. Ann Surg 2011; 253: 1024–1032.
18. Kuo YR, Wu WS, Hsieh YL, et al. Extracorporeal shock wave enhanced extended skin flap tissue survival via increase of topical blood perfusion and associated with suppression of tissue pro-inflammation. J Surg Res 2007; 143: 385–392.
19. Kuo YR, Wang CT, Wang FS, et al. Extracorporeal shock wave treatment modulates skin fibroblast recruitment and leukocyte infiltration for enhancing extended skin-flap survival. Wound Repair Regen 2009; 17: 80–87.
20. Silveira A, Koenig JB, Arroyo LG, et al. Effects of unfocused extracorporeal shock wave therapy on healing of wounds of the distal portion of the forelimb in horses. Am J Vet Res 2010; 71: 229–234.
21. Schaden W, Thiele R, Kölpl C, et al. Shock wave therapy for acute and chronic soft tissue wounds: a feasibility study. J Surg Res 2007; 143: 1–12.
22. Rozen S, Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132: 365–386.
23. Smits K, Goossens K, Van Soom A, et al. Selection of reference genes for quantitative real-time PCR in equine in vivo and fresh and frozen-thawed in vitro blastocysts. BMC Res Notes [serial online.] 2009; 2:246. Available at: www.biomedcentral.com/1756-0500/2/246. Accessed May 31, 2010.
24. Zhang YW, Davis EG, Bai J. Determination of internal control for gene expression studies in equine tissues and cell culture using quantitative RT-PCR. Vet Immunol Immunopathol 2009; 130: 114–119.
25. Bogaert L, Van Poucke M, De Baere C, et al. Selection of a set of reliable reference genes for quantitative real-time PCR in normal equine skin and in equine sarcoids. BMC Biotechnol [serial online]. 2006; 6:24. Available at: www.biomedcentral.com/1472-6750/6/24. Accessed Sep 26, 2011.
26. Wang CJ, Wang FS, Yang KD, et al. Shock wave therapy induces neovascularization at the tendon-bone junction. A study in rabbits. J Orthop Res 2003; 21: 984–989.
27. Junge L, Ohl CD, Wolfrum B, et al. Cell detachment method using shock-wave–induced cavitation. Ultrasound Med Biol 2003; 29: 1769–1776.
28. Kamelger F, Oehlbauer M, Piza-Katzer H, et al. Extracorporeal shock wave treatment in ischemic tissues: what is the appropriate number of shock wave impulses? J Reconstr Microsurg 2010; 26: 117–121.
29. Morgan DD, McClure S, Yaeger MJ, et al. Effects of extracorporeal shock wave therapy on wounds of the distal portion of the limbs in horses. J Am Vet Med Assoc 2009; 234: 1154–1161.
30. Ehrlich HP, Wyler DJ. Fibroblast contraction of collagen lattices in vitro: inhibition by chronic inflammatory cell mediators. J Cell Physiol 1983; 116: 345–351.
31. Kovacs EJ. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today 1991; 12: 17–23.
32. van den Boom R, Wilmink JM, O'Kane S, et al. Transforming growth factor-beta levels during second-intention healing are related to the different course of wound contraction in horses and ponies. Wound Repair Regen 2002; 10: 188–194.
33. Theoret CL, Barber SM, Moyana TN, et al. Expression of transforming growth factor β1, β3, and basic fibroblast growth factor in full-thickness skin wounds of equine limbs and thorax. Vet Surg 2001; 30: 269–277.
34. Theoret CL, Barber SM, Moyana TN, et al. Preliminary observations on expression of transforming growth factors β1 and β3 in equine full-thickness skin wounds healing normally or with exuberant granulation tissue. Vet Surg 2002; 31: 266–273.
35. Lefebvre-Lavoie J, Lussier JG, Theoret CL. Profiling of differentially expressed genes in wound margin biopsies of horses using suppression subtractive hybridization. Physiol Genomics 2005; 22: 157–170.
Advertisement
Objective—To compare the effect of extracorporeal shock wave therapy (ESWT) on expression of fibroblast growth factor-7 (FGF-7), transforming growth factor-β1 (TGF-β1), insulin-like growth factor-1 (IGF-1), platelet-derived growth factor-A (PDGF), and vascular endothelial growth factor-A (VEGF) in skin with surgically created skin wounds and intact skin in horses.
Animals—14 healthy horses.
Procedure—8 horses were treated with ESWT at 6 locations along the neck at 36, 24, 12, 6, 2, or 1 hour prior to collection of full-thickness biopsy specimens from each location; a control specimen was collected from a sham-treated location. In 6 horses, 5 full-thickness wounds were created in each forelimb. Wounds in 1 forelimb/horse received ESWT immediately after creation and subsequently on days 7, 14, and 21; wounds in the contralateral forelimb remained untreated. Biopsy specimens were collected from 1 wound on each forelimb on days 7, 14, 21, 28, and 35. Expression levels of FGF-7, TGF-β1, IGF-1, PDGF, and VEGF were assessed in tissue samples from the horses' necks and forelimbs.
Results—In surgically created wounds, ESWT treatment was associated with reduced TGF-β1 expression, compared with expression in control wounds, during the entire study period. At 28 days following wound creation, IGF-1 expression was significantly increased for treated and untreated wounds, compared with findings on days 7, 14, 21, and 35. There was no significant effect of treatment on FGF-7, TGF-β1, IGF-1, PDGF, or VEGF expression in intact skin.
Conclusions and Clinical Relevance—Intervention with ESWT to suppress TGF-β1 may decrease granulation tissue production, resulting in improved wound healing on the distal portion of horses' limbs.
Supported in part by Equine Guelph.
The authors thank Gabrielle Monteith for assistance with the statistical analysis and Dr. Jutta Hammermueller for technical assistance.